Derivative exercise or conversion — not an open-market buy.
Traded Oct 24, 2025 · Filed Oct 28, 2025
Thermo Fisher Scientific's Executive Vice President sold $230K of Thermo Fisher Scientific shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$229,660
Shares × reported transaction price
2 days after results of Oct 22, 2025, 97 days before results of Jan 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $572.50 on Oct 24, 2025, 47% above its 52-week low and 6% below its high, after a 19% rise over the previous 30 trading days
52-week range $390.26 (Jun 17, 2025) to $606.74 (Jan 30, 2025), 84% of the way up, from 250 adjusted closes. 30 trading days earlier: $479.46 on Sep 12, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.7% | -1.4% | +3.1% |
| 30 days | +5.8% | -0.6% | +6.4% |
| 90 days | +11.8% | +1.2% | +10.6% |
| 180 days | -16.2% | +4.0% | -20.2% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$5.08M of Thermo Fisher Scientific
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.